Resuscitation of the patient with suspected/confirmed COVID-19 when wearing personal protective equipment: A randomized multicenter crossover simulation trial.
Marek MalyszAgnieszka SzarpakBernd W BöttigerJacek SmerekaAgnieszka SzarpakKrzysztof J FilipiakMilosz Jaroslaw JaguszewskiKrzysztof Jerzy FilipiakJerzy Robert ŁadnyLukasz SzarpakPublished in: Cardiology journal (2020)
According to the results of this simulation trial, automated chest compression devices (ACCD) should be used for chest compression of patients with suspected/confirmed COVID-19. In the absence of ACCD, it seems reasonable to change the cardiopulmonary resuscitation algorithm (in the context of patients with suspected/confirmed COVID-19) by reducing the duration of the cardiopulmonary resuscitation cycle from the current 2-min to 1-min cycles due to a statistically significant reduction in the quality of chest compressions among rescuers wearing PPE AGP.
Keyphrases
- quality improvement
- cardiopulmonary resuscitation
- cardiac arrest
- coronavirus disease
- sars cov
- machine learning
- phase iii
- study protocol
- clinical trial
- deep learning
- phase ii
- respiratory syndrome coronavirus
- open label
- case report
- double blind
- randomized controlled trial
- pulmonary embolism
- cross sectional
- placebo controlled